Deubiquitination-related genes define immune subtypes of colorectal cancer and are associated with prognosis and immunotherapy-related signatures.
1/5 보강
[UNLABELLED] Colorectal cancer (CRC) is highly heterogeneous, and the contribution of deubiquitination (DUB) programs to immune context and clinical outcome remains incompletely defined.
APA
Xu Y, Mo Z, et al. (2026). Deubiquitination-related genes define immune subtypes of colorectal cancer and are associated with prognosis and immunotherapy-related signatures.. Scientific reports, 16(1), 4862. https://doi.org/10.1038/s41598-026-35271-5
MLA
Xu Y, et al.. "Deubiquitination-related genes define immune subtypes of colorectal cancer and are associated with prognosis and immunotherapy-related signatures.." Scientific reports, vol. 16, no. 1, 2026, pp. 4862.
PMID
41507372
Abstract
[UNLABELLED] Colorectal cancer (CRC) is highly heterogeneous, and the contribution of deubiquitination (DUB) programs to immune context and clinical outcome remains incompletely defined. We integrated transcriptomes from TCGA and GTEx (COAD/READ) with an external GEO cohort (GSE39582) to delineate DUB-associated features. Differential expression and univariate survival analyses yielded DUB-related, prognosis-associated genes, which were used for consensus clustering to derive CRC subtypes. Functional enrichment (GO/KEGG) and preranked GSEA characterized pathways; a STRING–Cytoscape–cytoHubba workflow identified hub genes; immune landscapes were profiled by CIBERSORT together with immune-checkpoint, immunogenic cell death (ICD) and HLA gene sets, and computational immunotherapy-related metrics (TIDE, IPS). Seventeen key DUB-related genes enriched in cell-cycle/DNA-damage response and ECM/EMT programs classified tumors into two robust subtypes with distinct overall survival, clinicopathologic profiles and transcriptional signatures. Sixty-six cluster-related DEGs formed an interaction network that highlighted nine ECM-centric hub genes with consistent prognostic value across TCGA and GEO. Subtypes differed markedly in immune-cell infiltration and in ICG/ICD/HLA expression, with clear separation of TIDE and IPS scores, indicating distinct computational immunotherapy-related signatures. These results define interpretable DUB-anchored immune subtypes and nominate hub genes as candidate biomarkers to support prognosis assessment and facilitate hypothesis-generating immunotherapy-related stratification. Prospective and functional validation is warranted, and this study should be interpreted as an exploratory analysis based on publicly available transcriptomic datasets.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1038/s41598-026-35271-5.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1038/s41598-026-35271-5.
같은 제1저자의 인용 많은 논문 (5)
- Independent Risk Factors and Nomogram-Based Prediction of Pulmonary Fungal Infection in Lung Cancer Inpatients: A Single-Center Retrospective Study.
- CRISPR-based metabolic screening identifies PLCE1 as a pivotal regulator of oncolytic viral antitumor immunity via tumor immune microenvironment remodeling.
- Design, synthesis of 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole derivatives as potential anticancer agents.
- A Retrospective Comparative Study on the Omission Versus Placement of Chest Drain Following Thoracoscopic Sublobar Resection.
- Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States.